References
- Knudsen J H, Kjærsgaard E, Jensen E W, Christensen N J. Percentage of NK cells in peripheral blood in resting normal subjects is negatively correlated to plasma adrenaline. Scand J Clin Lab Invest 1994; 54: 221–5
- van Tits L JH, Michel M C, Grosse-Wilde H, et al. Catecholamines increase lymphocyte beta2-adrenergic receptors via a beta2-adrenergic, spleen-dependent process. Am J Physiol 1990; 258: E191–202
- Tønnesen E, Christensen N J, Brinkløv M M. Natural killer cell activity during cortisol and adrenaline infusion in healthy volunteers. Eur J Clin Invest 1987; 17: 497–503
- Maisel A S, Harris T, Rearden A, Michel M C. Beta-adrenergic receptors in lymphocyte subsets after exercise. Alterations in normal individuals and patients with congestive heart failure. Circulation 1990; 82: 2003–10
- Maisel A S, Fowler P, Rearden A, Motulsky H J, Michel M C. A new method for isolation of human lymphocyte subsets reveals differential regulation of beta-adrenergic receptors by terbutaline treatment. Clin Pharmacol Ther 1989; 46: 429–39
- Landmann R. Beta-adrenergic receptors in human leucocyte subpopulations. Eur J Clin Invest 1992; 22(Suppl 1)30–6
- Kent R S, De Lean A, Lefkowitz R J. A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modelling of ligand binding data. Mol Pharmacol 1980; 17: 14–23
- Griese M, Körholz U, Körholz D. Density and agonist-promoted high and low affinity states of the β-adrenoceptor on human B- and T-cells. Eur J Clin Invest 1983; 13: 339–46
- Beckner S K, Farrar W L. Potentiation of lymphokine-activated killer cell differentiation and lymphocyte proliferation by stimulation of protein kinase C or inhibition of adenylate cyclase. J Immunol 1988; 140: 208–14
- Vitte-Mony I, Stancou R, Bertoglio J H. Functional consequences of cAMP accumulation in human natural killer cells. Implications for IL-2 and IL-4 signaltransduction. J Immunol 1990; 145: 4272–8
- Vitte-Mony I, Goy A, Guizani L, Bertoglio J H. Cyclic AMP upregulates mRNA and surface expression of IL-2R alpha p55(Tac) in normal human NK cell clones. Mol Immunol 1992; 29: 593–600
- Goto T, Herberman R B, Maluish A, Strong D M. Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity. J Immunol 1983; 130: 1350–5
- Lanefelt F, Ullberg M, Jondal M, Fredholm B B. PGE1 and prostacyclin suppression of NK-cell mediated cytotoxicity and its relation to cyclic AMP. Med Biol 1983; 61: 324–30
- Ullberg M, Jondal M, Lanefelt F, Fredholm B B. Inhibition of human NK cell cytotoxicity by induction of cyclic AMP depends on impaired target cell recognition. Scand J Immunol 1983; 17: 365–73
- Johansen T, Friis U G, Rasmussen A K, Foged N. The effect of in vitro procedures on cyclic AMP accumulation in human leucocytes. Scand J Clin Lab Invest 1994; 54: 127–35